Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01IMJ
|
||||
Former ID |
DNC007415
|
||||
Drug Name |
N-(4-methylthiazol-2-yl)benzamide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528805] | ||
Structure |
Download2D MOL |
||||
Formula |
C11H10N2OS
|
||||
Canonical SMILES |
CC1=CSC(=N1)NC(=O)C2=CC=CC=C2
|
||||
InChI |
1S/C11H10N2OS/c1-8-7-15-11(12-8)13-10(14)9-5-3-2-4-6-9/h2-7H,1H3,(H,12,13,14)
|
||||
InChIKey |
NEPIZAVYXKHUCD-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | mRNA of human 5-lipoxygenase | Target Info | Inhibitor | [528805] | |
NetPath Pathway | IL4 Signaling Pathway | ||||
PathWhiz Pathway | Arachidonic Acid Metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.